Cargando…
Usefulness of Danaparoid sodium in patients with Heparin-induced thrombocytopenia after cardiac surgery
OBJECTIVE: Thrombocytopenia is a common problem in cardiovascular surgery patients. However, heparin-induced thrombocytopenia (HIT) is a rare but life-threatening complication of prophylaxis or treatment with heparin. Prompt management of HIT with an alternative anticoagulant is necessary due to the...
Autores principales: | Foroughinia, Farzaneh, Farsad, Fariborz, Gholami, Kheirollah, Ahmadi, Somayeh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4418139/ https://www.ncbi.nlm.nih.gov/pubmed/25984544 http://dx.doi.org/10.4103/2279-042X.155754 |
Ejemplares similares
-
Experience of danaparoid to treat vaccine-induced immune thrombocytopenia and thrombosis, VITT
por: Myllylahti, Lasse, et al.
Publicado: (2022) -
Commentary: Are platelet patterns repeated in delayed heparin-induced thrombocytopenia/heparin-induced thrombocytopenia and thrombosis syndrome after cardiac surgery?
por: Kramer, Robert S., et al.
Publicado: (2020) -
Danaparoid sodium-based anticoagulation therapy for portal vein thrombosis in cirrhosis patients
por: Hayashi, Takehiro, et al.
Publicado: (2019) -
Enoxaparin-sodium/heparin: Heparin-induced thrombocytopenia: case report
Publicado: (2021) -
Danaparoid sodium inhibits systemic inflammation and prevents endotoxin-induced acute lung injury in rats
por: Hagiwara, Satoshi, et al.
Publicado: (2008)